n/a
Article Publish Status: FREE
Abstract Title:

Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer.

Abstract Source:

Cancer Discov. 2020 Oct ;10(10):1489-1499. Epub 2020 Jul 20. PMID: 32690541

Abstract Author(s):

Adam Pennycuick, Vitor H Teixeira, Khalid AbdulJabbar, Shan E Ahmed Raza, Tom Lund, Ayse U Akarca, Rachel Rosenthal, Lukas Kalinke, Deepak P Chandrasekharan, Christodoulos P Pipinikas, Henry Lee-Six, Robert E Hynds, Kate H C Gowers, Jake Y Henry, Fraser R Millar, Yeman B Hagos, Celine Denais, Mary Falzon, David A Moore, Sophia Antoniou, Pascal F Durrenberger, Andrew J Furness, Bernadette Carroll, Claire Marceaux, Marie-Liesse Asselin-Labat, William Larson, Courtney Betts, Lisa M Coussens, Ricky M Thakrar, Jeremy George, Charles Swanton, Christina Thirlwell, Peter J Campbell, Teresa Marafioti, Yinyin Yuan, Sergio A Quezada, Nicholas McGranahan, Sam M Janes

Article Affiliation:

Adam Pennycuick

Abstract:

Before squamous cell lung cancer develops, precancerous lesions can be found in the airways. From longitudinal monitoring, we know that only half of such lesions become cancer, whereas a third spontaneously regress. Although recent studies have described the presence of an active immune response in high-grade lesions, the mechanisms underpinning clinical regression of precancerous lesions remain unknown. Here, we show that host immune surveillance is strongly implicated in lesion regression. Using bronchoscopic biopsies from human subjects, we find that regressive carcinomalesions harbor more infiltrating immune cells than those that progress to cancer. Moreover, molecular profiling of these lesions identifies potential immune escape mechanisms specifically in those that progress to cancer: antigen presentation is impaired by genomic and epigenetic changes,signaling is upregulated, and the immunomodulatoris downregulated. Changes appear intrinsic to the carcinomalesions, as the adjacent stroma of progressive and regressive lesions are transcriptomically similar. SIGNIFICANCE: Immune evasion is a hallmark of cancer. For the first time, this study identifies mechanisms by which precancerous lesions evade immune detection during the earliest stages of carcinogenesis and forms a basis for new therapeutic strategies that treat or prevent early-stage lung cancer...

Study Type : Human In Vitro

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.